Article
HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.
AIDS research and therapy - 7 Feb 2020
Matume Nontokozo D, Tebit Denis M, Bessong Pascal O
Abstract excerpt
BACKGROUND: Entry inhibitors, such as Maraviroc, hold promise as components of HIV treatment and/or pre-exposure prophylaxis in Africa. Maraviroc inhibits the interaction between HIV Envelope gp120 V3-loop and CCR5 coreceptor. HIV-1 subtype C (HIV-1-C) is predominant in Southern Africa and preferably uses CCR5 co-receptor. Therefore, a significant proportion of HIV-1-C CXCR4 utilizing viruses (X4) may compromise...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
